Submit Deal

ESSA PHARMA

HQ - Vancouver

Summary

ESSA Pharma is a clinical-stage pharmaceutical company focused on the development of novel and targeted therapies for the treatment of prostate cancer.

Deals Overview

Total Deals2

Valued Deals1

Total Value£ 17 M

Avg. Deal Size£ 17 M

Market Context

Senior Management

David Parkinson
CEO
David Wood
CFO

Sort

fti consulting

HQ - Washington DC

pr advisors (1)

1 Shared Deal

1 Opposite

£ 17 M

Total Value

fasken

HQ - Toronto

legal advisors (1)

1 Shared Deal

1 Opposite

£ 17 M

Total Value

mts health partners

HQ - New York, United States

financial advisors (1)

1 Shared Deal

1 Opposite

£ 17 M

Total Value

cooley

HQ - Palo Alto

legal advisors (1)

1 Shared Deal

1 Opposite

£ 17 M

Total Value

skadden arps slate meagher & flom

HQ - New York

legal advisors (2)

2 Shared Deals

2 For

£ 17 M

Total Value

oppenheimer & co

HQ - New York

financial advisors (1)

1 Shared Deal

1 For

£ 17 M

Total Value

blake cassels & graydon

HQ - Toronto

legal advisors (2)

2 Shared Deals

2 For

£ 17 M

Total Value

eversheds sutherland

HQ - London

legal advisors (1)

1 Shared Deal

1 For

£ 17 M

Total Value

leerink partners

HQ - Boston, MA, United States

financial advisors (1)

1 Shared Deal

1 For

n/a

Total Value

collected strategies

HQ - New York

pr advisors (1)

1 Shared Deal

1 For

n/a

Total Value

stikeman elliott

HQ - Montreal

legal advisors (1)

1 Shared Deal

1 Opposite

n/a

Total Value

gibson dunn & crutcher

HQ - Los Angeles

legal advisors (1)

1 Shared Deal

1 Opposite

n/a

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy